4-5628743-TAA-TAAA
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_147127.5(EVC2):c.1711-10dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 32 hom., cov: 0)
Exomes 𝑓: 0.013 ( 12 hom. )
Consequence
EVC2
NM_147127.5 intron
NM_147127.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.151
Publications
4 publications found
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
- acrofacial dysostosis, Weyers typeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- Ellis-van Creveld syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 4-5628743-T-TA is Benign according to our data. Variant chr4-5628743-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1168233.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0123 (1828/148734) while in subpopulation AFR AF = 0.0399 (1634/40936). AF 95% confidence interval is 0.0383. There are 32 homozygotes in GnomAd4. There are 872 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 32 AR,AD gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EVC2 | ENST00000344408.10 | c.1711-10dupT | intron_variant | Intron 11 of 21 | 1 | NM_147127.5 | ENSP00000342144.5 | |||
| EVC2 | ENST00000310917.6 | c.1471-10dupT | intron_variant | Intron 11 of 21 | 1 | ENSP00000311683.2 | ||||
| EVC2 | ENST00000475313.5 | n.1471-10dupT | intron_variant | Intron 11 of 22 | 1 | ENSP00000431981.1 | ||||
| EVC2 | ENST00000509670.1 | n.*104-10dupT | intron_variant | Intron 12 of 22 | 1 | ENSP00000423876.1 |
Frequencies
GnomAD3 genomes AF: 0.0123 AC: 1827AN: 148626Hom.: 32 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
1827
AN:
148626
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0108 AC: 2028AN: 187796 AF XY: 0.0104 show subpopulations
GnomAD2 exomes
AF:
AC:
2028
AN:
187796
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0126 AC: 14991AN: 1193360Hom.: 12 Cov.: 0 AF XY: 0.0124 AC XY: 7324AN XY: 592584 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
14991
AN:
1193360
Hom.:
Cov.:
0
AF XY:
AC XY:
7324
AN XY:
592584
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
1676
AN:
31030
American (AMR)
AF:
AC:
290
AN:
38272
Ashkenazi Jewish (ASJ)
AF:
AC:
211
AN:
20526
East Asian (EAS)
AF:
AC:
79
AN:
35086
South Asian (SAS)
AF:
AC:
1481
AN:
68674
European-Finnish (FIN)
AF:
AC:
412
AN:
43706
Middle Eastern (MID)
AF:
AC:
64
AN:
4802
European-Non Finnish (NFE)
AF:
AC:
10104
AN:
901848
Other (OTH)
AF:
AC:
674
AN:
49416
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.279
Heterozygous variant carriers
0
1936
3872
5807
7743
9679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0123 AC: 1828AN: 148734Hom.: 32 Cov.: 0 AF XY: 0.0120 AC XY: 872AN XY: 72486 show subpopulations
GnomAD4 genome
AF:
AC:
1828
AN:
148734
Hom.:
Cov.:
0
AF XY:
AC XY:
872
AN XY:
72486
show subpopulations
African (AFR)
AF:
AC:
1634
AN:
40936
American (AMR)
AF:
AC:
87
AN:
14986
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3412
East Asian (EAS)
AF:
AC:
0
AN:
5096
South Asian (SAS)
AF:
AC:
50
AN:
4654
European-Finnish (FIN)
AF:
AC:
6
AN:
9716
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
22
AN:
66702
Other (OTH)
AF:
AC:
29
AN:
2050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
85
170
256
341
426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:2
Dec 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Aug 20, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.